Effects of Hyperbaric Oxygen Therapy on Lungs Histopathology of Animal Models with Chronic Obstructive Pulmonary Disease
Article Sidebar
Main Article Content
Abstract
Chronic obstructive pulmonary disease (COPD) is a respiratory or alveolar tract disorder characterized by inflammation with high morbidity and mortality rates. The increasing mortality rate among workers in certain jobs emphasizes the importance of targeted interventions to prevent COPD development. This study aimed to investigate the effects and mechanisms of hyperbaric oxygen therapy (HBOT) intervention in reducing inflammation in COPD animal models. Twenty-one female Wistar rats aged 6-8 weeks weighing between 180-200 g were used in this study. They were divided into 3 groups: G0 (negative control), G1 (COPD group without HBOT treatment), and G2 (COPD group with HBOT treatment). The HBOT dose includes breathing 98.2% O2 of 1.3 ATA 3 times at 30-minute, intervals 2 times for 5 minutes normal air, for 5 consecutive days, interspersed with 2 days of rest then 5 more consecutive days in the animal chamber. SOD and IL-1β levels in the rats' blood serum were examined using the ELISA method. Hematoxylin-eosin (HE) staining technique was used to examine the expression of inflammatory cells in the rats’ lung tissue. The Games-Howell test showed a non-significant decrease in IL-1β levels (p > 0.05) and a significant increase in SOD enzyme activity (p<0.05) in G2 compared to G1. The histopathology results revealed a significant decrease in inflammatory cell expression in lung alveoli tissue (p = 0.029, p<0.05) in G2 compared to G1. The study concludes that HBOT exhibited anti-inflammatory effects in animal models of COPD and can be used as adjuvant therapy in the management of COPD.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes, Bourbeau, Han MK, Martinez FJ, de Oca MM, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, 18 M. Victorina López Varela MVL, Wedzicha JA, Vogelmeier CF. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023; 207(7): 819–837.
Brandsma CA, Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol. 2020; 250: 624–635.
Yawn BP, Mintz ML, Doherty DE. GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting. Int J Chron Obstruct Pulmon Dis. 2021; 16: 289–299.
Boers E, Barrett M, Su JG, Benjafield AV, Sinha S, Kaye L, Zar HJ, Vuong V, Tellez D, Gondalia R, Rice M, Nunez CM, Wedzicha JA, Malhotra A. Global Burden of Chronic Obstructive Pulmonary Disease Through 2050. JAMA Network Open. 2023; 6(12):e2346598.
Chung C, Lee KN, Han K, Shin DW, Lee SW. Effect of smoking on the development of chronic obstructive pulmonary disease in young individuals: a nationwide cohort study. Front Med (Lausanne). 2023; 10: 1190885.
Mathioudakis AG, Vanfleteren LEGW, Lahousse L, Higham A, Allinson JP, Gotera C, Visca D, Singh D, Spanevello A. Current developments and future directions in COPD. ERS. 2020; 29(158):1–12.
Kim JJ, Kim YS, Kumar V. Heavy metal toxicity: An update of chelating therapeutic strategies. J Trace Elem Med Biol. 2019; 54: 226–231.
Sassykova LR, Aubakirov YA, Sendilvelan S, Tashmukhambetova ZK. The Main Components of Vehicle Exhaust Gases and Their Effective Catalytic Neutralization. Orient J Chem. 2019; 35(1): 110–127.
He F, Liao B, Pu J, Li C, Zheng M, Huang L, Zhou Y, Zhao D, Li B, Ran P. Exposure to Ambient Particulate Matter Induced COPD in a Rat Model and a Description of the Underlying Mechanism. Sci Rep. 2017; 7:45666.
Kilowasid LMH, Herlina H, Syaf LO, Safuan M, Tufaila S, Leomo B, Kim JJ, Kim YS, Kumar, V. Heavy metal toxicity: An update of chelating therapeutic strategies. J Trace Elem Med Biol. 2019; 54:226–231.
Ahmida M, Zadam MH, Boumendje A, Messarah M, Moncef Z, Hocine D, Bensouici C, Boumendje M. UPLC-MS/MS Analysis and Evaluation of the Photoprotective, Antioxidant, Anti-Inflammatory and Anti-Enzymatic Properties of Ethyl Acetate and n-Butanol Fractions from Algerian Juniperus oxycedrus L.Leaves. Trop J Nat Prod Res. 2024; 8(7):7639-7649.
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allerg Clin Immunol. 2019; 138(1):16-27.
Osei ET, Brandsma CA, Timens W, Heijink IH, Hackett T. Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD. Eur Respir J. 2010; 55: 1900563.
Rumora L, Hlapčić I, Popović-Grle S, Rako I, Rogić D, Čepelak I. Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta. PLOS ONE. 2020; 15(1): e0228930.
Bent R, Moll L, Grabbe, Bros M. Interleukin-1 Beta—A Friend or Foe in Malignancies?. Int J Mol Sci. 2018; 19(8): 2155.
Rosario ER, Kaplan SE, Khonsari S, Vazquez G, Solanki N, Lane M, Brownell H, Rosenberg SS. The Effect of Hyperbaric Oxygen Therapy on Functional Impairments Caused by Ischemic Stroke. Neurol Res Int. 2018; 18:12.
Hadanny A, Zubari T, Tamir-Adler LT, Bechor Y, Fishlev G, Lang E, Polak N, Bergan J, Friedman M, Efrati S. Hyperbaric oxygen therapy effects on pulmonary functions: A prospective cohort study. BMC Pulm Med. 2018; 19(1):1–7.
Holf J. Methods of Blood Collection in the Mice. Technique. 2010; 29:10
Sari NNAK, Sulchan M, Afifah DN. Effects of patin fish oil and turmeric extract on levels of malondialdehyde and superoxide dismutase in Wistar rat models of metabolic syndrome. Aceh Nutri J. 2024; 9:2.
Balqis U, Muslina, Hambal M, Athaillah F, Muttaqien, Azhar, Ismail, Rastina, Eliawardani, Harris A, Hamzah A, Vanda H. and Darmawi. Histopathological changes in egg cells in the uterus Ascaridia galli after adding seed extract Veitchia merrillii. Trad Med J. 2017; 22(3):139-145.
Singer M, Young PJ, Laffey JG, Asfar P, Taccone FS, Krifvars MB, Meyhoff CS, Radermacher P. Dangers of Hyperoxia. Crit Care. 2021; 25:440.
Gawdi R and Cooper JS. Hyperbaric Contraindications. Text Book. National Library of Medicine. May 8, 2022.
Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020; 877:173090.
He F, Liao B, Pu J, Li C, Zheng M, Huang L, Zhou Y, Zhao D, Li B, Ran P. Exposure to Ambient Particulate Matter Induced COPD in a Rat Model and a Description of the Underlying Mechanism. Sci Rep. 2017; 7:45666.
Harnanik T, Soeroso J, Suryokusumo MG, Juliandhy J. Effects of Hyperbaric Oxygen on T helper 17/regulatory T Polarization in Antigen and Collagen-induced Arthritis: Hypoxia-inducible Factor-1α as a Target. Oman Med J. 2020; 35(1):e90.
Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. PLoS One. 2016; 11(4):e0152925.
Quiñonez-Flores CM, González-Chávez SA, Del Río Nájera D, Pacheco-Tena C. Oxidative stress relevance in the pathogenesis of rheumatoid arthritis: A systematic review. Biomed Res Int. 2016; 2016: 6097417.
Körpınar S and Uzun H. The Effects of Hyperbaric Oxygen at Different Pressures on Oxidative Stress and Antioxidant Status in Rats. Medicina (Kaunas). 2019; 55(5):205.
Kjellberg A, De Maio A, Lindholm P. Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19? Med Hypotheses. 2020; 144: 110224.